Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment.

Pediatric nephrology (Berlin, Germany) - 1 Aug 2017

Atmaca Mustafa, Gulhan Bora, Korkmaz Emine, Inozu Mihriban, Soylemezoglu Oguz, Candan Cengiz, Bayazıt Aysun Karabay, Elmacı Ahmet Midhat, Parmaksiz Gonul, Duzova Ali, Besbas Nesrin, Topaloglu Rezan, Ozaltin Fatih

Abstract excerpt

BACKGROUND: ADCK4-related glomerulopathy is an important differential diagnosis in adolescents with steroid-resistant nephrotic syndrome (SRNS) and/or chronic kidney disease (CKD) of unknown origin. We screened adolescent patients to determine the frequency of ADCK4 mutation and the efficacy of early CoQ10 administration. METHODS: A total of 146 index patients aged 10-18 years, with newly diagnosed non-nephrotic...

Topics

Join the communities discussing this publication.

Ubiquinone
Albuminuria
Glomerular Filtration Rate
Glucocorticoids
Kidney Failure, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Nephrotic Syndrome

Source

Identifiers

PMID: 28337616
DOI: 10.1007/s00467-017-3634-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment.PMID 28337616Read ↗

Long-term follow-up results of patients with ADCK4 mutations who have been diagnosed in the asymptomatic period: effects of early initiation of CoQ10 supplementation.Semantic proximity Read ↗

Early-onset of ADCK4 glomerulopathy with renal failure: a case report.Semantic proximity Read ↗

ADCK4-Associated Glomerulopathy Causes Adolescence-Onset FSGS.Semantic proximity Read ↗

Focal segmental glomerulosclerosis and medullary nephrocalcinosis in children with ADCK4 mutations.Semantic proximity Read ↗

Early-onset COQ8B (ADCK4) glomerulopathy in a child with isolated proteinuria: a case report and literature review.Semantic proximity Read ↗

Coenzyme Q10 supplementation therapy for 2 children with proteinuria renal disease and ADCK4 mutation: Case reports and literature review.Semantic proximity Read ↗

COQ8B nephropathy: Early detection and optimal treatment.Semantic proximity Read ↗

ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.Semantic proximity Read ↗

COQ8B nephropathy: early detection and optimal treatmentSemantic proximity Read ↗

Oral Coenzyme Q10 supplementation leads to better preservation of kidney function in steroid-resistant nephrotic syndrome due to primary Coenzyme Q10 deficiency.Semantic proximity Read ↗

A new era for steroid-resistant nephrotic syndrome in childhood.Semantic proximity Read ↗

Urinary coenzyme Q10 as a diagnostic biomarker and predictor of remission in a patient with ADCK4-associated Glomerulopathy: a case report.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.